De Martini, L. B., Valori, C. F., Morrone, M., Brambilla, L., & Rossi, D. (2026). Intranasal vs. Device-Assisted Drug Delivery: Advantages and Limitations for the Delivery of Biopharmaceuticals to the CNS. Pharmaceutics, 18(4), 484. https://doi.org/10.3390/pharmaceutics18040484
Chicago Style (17th ed.) CitationDe Martini, Lisa Benedetta, Chiara Flora Valori, Martina Morrone, Liliana Brambilla, and Daniela Rossi. "Intranasal Vs. Device-Assisted Drug Delivery: Advantages and Limitations for the Delivery of Biopharmaceuticals to the CNS." Pharmaceutics 18, no. 4 (2026): 484. https://doi.org/10.3390/pharmaceutics18040484.
MLA (9th ed.) CitationDe Martini, Lisa Benedetta, et al. "Intranasal Vs. Device-Assisted Drug Delivery: Advantages and Limitations for the Delivery of Biopharmaceuticals to the CNS." Pharmaceutics, vol. 18, no. 4, 2026, p. 484, https://doi.org/10.3390/pharmaceutics18040484.